{
    "clinical_study": {
        "@rank": "70465", 
        "arm_group": [
            {
                "arm_group_label": "Catheter Venography & Balloon Venoplasty", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will undergo catheter venography with balloon venoplasty procedure."
            }, 
            {
                "arm_group_label": "Catheter Venography Only", 
                "arm_group_type": "Sham Comparator", 
                "description": "Patients will undergo catheter venography only."
            }
        ], 
        "brief_summary": {
            "textblock": "To investigate the safety and tolerability of balloon venoplasty compared to sham in\n      Multiple Sclerosis patients with Chronic Cerebrospinal Venous Insufficiency (CCSVI) as\n      measured by adverse events occurring within 48 weeks of the procedure."
        }, 
        "brief_title": "Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis", 
                "Venous Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "Overview of study objectives are:\n\n        -  To determine the safety and tolerability of venoplasty of CCSVI in Multiple Sclerosis\n           (MS).\n\n        -  To determine the short term and long term impact on validated patient measures and by\n           physician and radiologic reported MS outcomes.\n\n        -  To determine the short term and long term recurrence rate of CCSVI for veins that have\n           been treated with venoplasty"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) or Secondary   Progressive\n             MS according to the McDonald criteria 2010\n\n          -  Age 18 to 65 years inclusive\n\n          -  Neurostatus (EDSS) score at screening from 0 to 6.5\n\n          -  Fulfill ultrasound criteria for CCSVI\n\n        Exclusion Criteria:\n\n          -  Previous venoplasty and/or stenting of extra cranial venous system"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01864941", 
            "org_study_id": "H12-01153"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Catheter Venography & Balloon Venoplasty", 
                    "Catheter Venography Only"
                ], 
                "description": "All eligible patients will undergo catheter venography with balloon venoplasty and/or sham at baseline and at week 48 (i.e. Cross over design) followed by clinical and radiologic observation for a minimum of 48 weeks after each procedure.", 
                "intervention_name": "Catheter venography with balloon venoplasty", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Catheter Venography & Balloon Venoplasty", 
                "intervention_name": "Catheter venography with balloon venoplasty and balloon", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Multiple Sclerosis", 
            "MS", 
            "CCSVI", 
            "Zamboni", 
            "catheter venography", 
            "balloon angioplasty"
        ], 
        "lastchanged_date": "December 10, 2013", 
        "link": [
            {
                "description": "Vancouver Coastal Health Research Institute - CCSVI Webpage", 
                "url": "http://www.vchri.ca/s/MS-CCSVI-LATEST.asp"
            }, 
            {
                "description": "Canadian Institutes of Health Research - CCSVI Trial News Release", 
                "url": "http://www.cihr-irsc.gc.ca/e/45919.html"
            }
        ], 
        "location": [
            {
                "contact": {
                    "email": "ccsvi@brain.ubc.ca", 
                    "last_name": "Laura Harvey"
                }, 
                "contact_backup": {
                    "email": "ccsvi@brain.ubc.ca", 
                    "last_name": "Jennifer Tzeng"
                }, 
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia", 
                        "zip": "V6T 2B5"
                    }, 
                    "name": "Vancouver Coastal Health - University of British Columbia Hospital"
                }, 
                "investigator": {
                    "last_name": "Anthony Traboulsee, FRCPC", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ccsvi@hsc.mb.ca", 
                    "last_name": "Nick Hall"
                }, 
                "contact_backup": {
                    "email": "ccsvi@hsc.mb.ca", 
                    "last_name": "Barbara Stanger"
                }, 
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba", 
                        "zip": "R3A 1R9"
                    }, 
                    "name": "University of Manitoba Health Sciences Centre"
                }, 
                "investigator": {
                    "last_name": "Reza Vosoughi, FRCPC", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "guylaine.lucier.chum@ssss.gouv.qc.ca", 
                    "last_name": "Guylaine Lucier"
                }, 
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H2L 4M1"
                    }, 
                    "name": "Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al"
                }, 
                "investigator": {
                    "last_name": "Marc Girard, FRCPC", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lucie.morel.cha@ssss.gouv.qc.ca", 
                    "last_name": "Lucie Morel"
                }, 
                "facility": {
                    "address": {
                        "city": "Quebec City", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "G1J 1Z4"
                    }, 
                    "name": "CHU de Qu\u00e9bec - H\u00f4pital de l'Enfant-J\u00e9sus"
                }, 
                "investigator": {
                    "last_name": "Francois Emond, FRCPC", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase I/II Interventional Clinical Trial of Balloon Venoplasty for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis Patients", 
        "overall_contact": {
            "email": "ccsvi@brain.ubc.ca", 
            "last_name": "Laura Harvey"
        }, 
        "overall_contact_backup": {
            "email": "ccsvi@brain.ubc.ca", 
            "last_name": "Jennifer Tzeng"
        }, 
        "overall_official": {
            "affiliation": "University of British Columbia", 
            "last_name": "Anthony Traboulsee, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To investigate the safety and tolerability of balloon venoplasty compared to sham in Multiple Sclerosis (MS) patients with CCSVI as measured by adverse events occurring within 48 weeks of the procedure.", 
            "measure": "Adverse Events", 
            "safety_issue": "Yes", 
            "time_frame": "48 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01864941"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To evaluate the efficacy of balloon venoplasty compared to sham as reflected by patient reported quality of life, pain and fatigue scales  48 weeks after the procedure.", 
                "measure": "Clinical Outcome", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "To evaluate the efficacy of balloon venoplasty compared to sham as reflected by physician reported clinical scales  48 weeks after the procedure.", 
                "measure": "Clinical Outcome", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "To evaluate the efficacy of balloon venoplasty compared to sham as reflected by MRI 48 weeks after the procedure.", 
                "measure": "Clinical Outcome", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "To evaluate the efficacy of balloon venoplasty compared to sham as reflected by catheter venography 48 weeks after the procedure.", 
                "measure": "Clinical Outcome", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }
        ], 
        "source": "University of British Columbia", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Canadian Institutes of Health Research  (CIHR)", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Multiple Sclerosis Society of Canada", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of British Columbia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}